Enoblituzumab Antibody
Enoblituzumab is a humanized monoclonal IgG1 antibody targeting the B7-H3 protein. It is a research tool for investigating solid tumors, including non-small cell lung cancer (NSCLC), in both in vitro and in vivo experimental models.
Product Specifications
Product Name Alternative
Enoblituzumab, MGA271, MGA-271, MGA 271, TJ 271, TJ271, TJ-271
Target
B7, Immunology/Inflammation related, Others
Clonality
Monoclonal
Conjugation
Unconjugated
Field of Research
Immunology & Inflammation
Concentration
5.55 mg/mL
Purity
95.00% (May vary between batches)
Molecular Weight
145.81 kDa
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS1442158-01 0.02 mg (E-Coli)
Recombinant Bacillus cereus Imidazolonepropionase (hutI)
Sign In for Pricing
View Details MBS1442158-02 0.02 mg (Yeast)
Recombinant Bacillus cereus Imidazolonepropionase (hutI)
Sign In for Pricing
View Details MBS1442158-03 0.1 mg (E-Coli)
Recombinant Bacillus cereus Imidazolonepropionase (hutI)
Sign In for Pricing
View Details MBS1442158-04 0.1 mg (Yeast)
Recombinant Bacillus cereus Imidazolonepropionase (hutI)
Sign In for Pricing
View Details